table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
potential COVID-19 treatments
adjuvant therapies
anticoagulant
anticoagulant, curative dose COALIZAO ACTION ATTACC, ACTIV-4a, and REMAP-CAP ...
heparin at therapeutic dose RAPID ...
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
anti GM-CSF
mavrilimumab MASH-COVID ...
clarithromycine Rashad ...
colchicine COLCOVID Salehzadeh GRECCO-19 RECOVERY ... Horby COL-COVID ...
Colchicine plus rosuvastatin Gaitan-Duarte ...
non-steroidal anti-inflammatory drugs
Indomethacin Ravichandran
stem cells Lanzoni Carmenate ...
corticosteroids
dexamethasone RECOVERY dexamethasone
methylprednisolone Tang X Metcovid Ranjbar
Immunostimulants drugs
convalescent plasma treatment ConCOVID ... ConPlas-19 COP-COVID-19 CONTAIN COVID-19 PC/COVID-19 NCT04397757 CONCOR-1 NCT04442191 DAWN-Plasma NCT04385199 COPLA-II trial NCT04403477 ... ASCOT RECOVERY ... CONFIDENT PERUCONPLASMA Bennett-Guerrero Salman Kirenga Co-CLARITY NCT04528368 Holm K CCAP-2 Baldeon Menichetti LIFESAVER Libster
Early convalescent plasma. Balcells
immunoglobulin therapy Sakoulas
interferon
IFN beta-1a SOLIDARITY ...
high-dose IFN beta-1a Darazam
inhaled interferon
IFN alpha
pegylated interferon-α2b Pandit Shashi Bhushan
recombinant super-compound interferon rSIFN-co Li
SNG001 inhaled interferon beta Synairgen SG016
interferon / TFF2 Fu
peginterferon Jagannathan
PNB001 Lattmann
neutralizing antibody ITAC
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) ACTIV-3 ...
bamlanivimab monotherapy ACTIV-3/TICO LY-CoV555
casirivimab/imdevimab (Ronapreve) RECOVERY ... Somersan-Karakaya ...
cilgavimab and tixagevimab (Evusheld) ACTIV-3/TICO ...
sotrovimab (Xevudy; VIR-7831) ACTIV-3/ TICO ...
Immunosuppressants drugs
anakinra SAVE-MORE CORIMUNO-ANA-1
anti-interleukin-6
sarilumab CORIMUNO-SARI-1 ...
tocilizumab Dongsheng Wang RCT-TCZ-COVID-19 EMPACTA RECOVERY Soin AS ... Rutgers NCT04412772 ... Declercq J ... NCT04577534 ... EU-CTR2020-001375-32 ... EU-CTR2020-001748-24 ... NCT04479358 ... NCT04434717 ... BACC Bay Tocilizumab Trial
canakinumab Sheng ...
janus kinase (JAK) inhibitor
baricitinib COV-BARRIER ACTT-2 ... RECOVERY
tofacitinib STOP-COVID ...
lenzilumab LIVE-AIR ...
leflunomide Wang
antiandrogenic
progesterone Ghandehari
antiviral and associated therapy
azithromycin Sekhavati RECOVERY ... COALITION I Covid-19 Brazil ... Rashad A ...
azvudine Ren
baloxavir marboxil Lou Y
bromhexine Li T
chloroquine and derivatives
chloroquine Huang
hydroxychloroquine HAHPS ORCHID RECOVERY SOLIDARITY ... Chen NO COVID-19 ... Abd-Elsalam TEACH HYCOVID Gonzalez ... NOR-Solidarity ... Coalition Covid-19 Brazil I ... FACCT Trial
Emtricitabine/tenofovir plus colchicine plus rosuvastatin Gaitan-Duarte ...
Ensitrelvir (XOCOVA) Mukae - Phase 2a
favipiravir Udwadia AVIFAVIR Lou ... Chang Chen et al. NCT04310228-FAVI ... Dabbous HM FACCT Trial Udwadia AVIFAVIR NCT04542694 Ruzhentsova T Solaymani-Dodaran Shinkai
favipiravir plus interferon Khamis
hydroxychloroquine plus macrolides
azithromycin plus hydroxychloroquine ProPAC-COVID Coalition Covid-19 Brazil I ...
ivermectin Gonzalez ... Shahbaznejad Chaccour Kirti Krolewiecki I-TECH ...
ivermectin plus doxycycline Hashim A NCT04523831 ...
lopinavir/ritonavir RECOVERY SOLIDARITY ... Nojomi Ader ... ELACOI ...
lopinavir/ritonavir plus interferon ß-1a Ader ...
lopinavir/ritonavir, ribavirin and interferon beta-1b Hung et al.
niclosamide Abdulamir
remdesivir NIH NIAID ACTT-1 DisCoVeRy ... SOLIDARITY ... Mahajan Norwegian NOR study ... Andreas ... GS-US-540-5774, 10 days GS-US-540-5774, 5 days GS-US-540-5773 ...
sofosbuvir Alavi-moghaddam
sofosbuvir and daclatasvir Sadeghi Yakoot Mobarak S ...
sofosbuvir and ledipasvir Elgohary Nourian A
tenofovir/emtricitabine Gaitan-Duarte ...
umifenovir (arbidol) Nojomi ELACOI ... ELACOI ...
Drugs for acid related disorders
H2 blockers
famotidine Samimagham
miscellaneous
Aspirin RECOVERY ...
camostat mesilate Gunst JD
Cannabidiol Crippa ...
sabizabulin VERU-111
Renin-angiotensin-system-acting agents
angiotensin receptor blockers (ARBs) Nouri-Vaskeh
losartan University of Minnesota
discontinuation of ACEI/ARB Lopes ...
Vitamins
Vitamin D Entrenas ... Murai

0 studies excluded by filtering options 0

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons